NRIIX
Price
$22.51
Change
-$0.04 (-0.18%)
Updated
Oct 7 closing price
Net Assets
1.14B
RIRHX
Price
$79.37
Change
-$0.09 (-0.11%)
Updated
Oct 7 closing price
Net Assets
120.2B
Interact to see
Advertisement

NRIIX vs RIRHX

Header iconNRIIX vs RIRHX Comparison
Open Charts NRIIX vs RIRHXBanner chart's image
Nuveen Real Asset Income I
Price$22.51
Change-$0.04 (-0.18%)
VolumeN/A
Net Assets1.14B
American Funds Capital Income Bldr R5E
Price$79.37
Change-$0.09 (-0.11%)
VolumeN/A
Net Assets120.2B
NRIIX vs RIRHX Comparison Chart in %
View a ticker or compare two or three
VS
NRIIX vs. RIRHX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRIIX is a Hold and RIRHX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RIRHX has more cash in the bank: 120B vs. NRIIX (1.14B). NRIIX pays higher dividends than RIRHX: NRIIX (4.87) vs RIRHX (3.08). NRIIX was incepted earlier than RIRHX: NRIIX (14 years) vs RIRHX (10 years). NRIIX (0.93) is less costly to investors than RIRHX (0.42). NRIIX is a more actively managed with annual turnover of: 82.00 vs. RIRHX (56.00). RIRHX has a lower initial minimum investment than NRIIX: RIRHX (250) vs NRIIX (100000). RIRHX annual gain was more profitable for investors over the last year : 12.54 vs. NRIIX (7.32). RIRHX return over 5 years is better than : 53.53 vs. NRIIX (35.16).
NRIIXRIRHXNRIIX / RIRHX
Total Expense Ratio0.910.42217%
Annual Report Gross Expense Ratio0.930.42221%
Fund Existence14 years10 years-
Gain YTD10.69017.62261%
Front LoadN/AN/A-
Min. Initial Investment10000025040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.14B120B1%
Annual Yield % from dividends4.873.08158%
Returns for 1 year7.3212.5458%
Returns for 3 years35.6750.5671%
Returns for 5 years35.1653.5366%
Returns for 10 years68.49N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SER5.400.21
+4.05%
Serina Therapeutics
EURKU10.89N/A
N/A
Eureka Acquisition Corp.
HLLY2.95-0.03
-1.01%
Holley
NVCR14.16-0.34
-2.34%
NovoCure Limited
BIO296.52-12.65
-4.09%
Bio-Rad Laboratories IncClass A